Lifecore Biomedical, Inc. (LFCR)
4.38
-0.08
(-1.79%)
USD |
NASDAQ |
Sep 01, 16:00
4.38
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Debt to Equity Ratio : 9.717 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.717 |
| March 31, 2026 | 7.226 |
| December 31, 2025 | |
| September 30, 2025 | |
| May 31, 2025 | 2.786 |
| February 28, 2025 | 2.748 |
| November 30, 2024 | 2.198 |
| August 31, 2024 | 3.465 |
| May 31, 2024 | 2.418 |
| February 29, 2024 | 2.124 |
| November 30, 2023 | 2.840 |
| August 31, 2023 | 4.466 |
| May 31, 2023 | 3.210 |
| February 28, 2023 | 1.746 |
| November 30, 2022 | 2.170 |
| August 31, 2022 | 1.954 |
| May 31, 2022 | 1.710 |
| February 28, 2022 | 0.9362 |
| November 30, 2021 | 1.174 |
| August 31, 2021 | 0.9128 |
| May 31, 2021 | 1.064 |
| February 28, 2021 | 1.048 |
| November 30, 2020 | 0.9389 |
| August 31, 2020 | 0.9087 |
| May 31, 2020 | 0.9575 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.8294 |
| November 30, 2019 | 0.8317 |
| August 31, 2019 | 0.7502 |
| May 31, 2019 | 0.565 |
| February 28, 2019 | 0.5443 |
| November 30, 2018 | 0.3369 |
| August 31, 2018 | 0.3303 |
| May 31, 2018 | 0.2891 |
| February 28, 2018 | 0.2381 |
| November 30, 2017 | 0.2529 |
| August 31, 2017 | 0.2623 |
| May 31, 2017 | 0.2385 |
| February 28, 2017 | 0.2346 |
| November 30, 2016 | 0.2522 |
| August 31, 2016 | 0.2591 |
| May 31, 2016 | 0.2943 |
| February 29, 2016 | 0.297 |
| November 30, 2015 | 0.2141 |
| August 31, 2015 | 0.1827 |
| May 31, 2015 | 0.1947 |
| February 28, 2015 | 0.2328 |
| November 30, 2014 | 0.2254 |
| August 31, 2014 | 0.1945 |
| May 31, 2014 | 0.1693 |
| February 28, 2014 | 0.1807 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Azenta, Inc. | 0.0357 |
| Danaher Corp. | 0.5298 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 229.50M |
| Total Liabilities (Quarterly) | 213.41M |
| Shareholders Equity (Quarterly) | 16.09M |
| Current Ratio | 3.867 |
| Net Debt Paydown Yield | -2.63% |